1 May

Addressing medicines shortages in the European Union

23 April

Future MEPs: take control to ensure access to medicines

5 March

Civil society letter calls for European Parliament to support global access to medical tools

1 March

Enabling Access to Medical Innovations for all

2 October

Flexibilities Navigator: An evermore valuable resource

24 January

Lack of diagnostics helps fuel AMR

27 January

Make good on access to medicine commitments HAI asks new Dutch Health Minister

17 January

Call for medical journals to support clinical trial transparency

21 December

Transparency: Bringing the Issue to Life

15 December

Working with the European Parliament

30 November

Talking Medicine Pricing

16 September

European Commission’s State of the Union address: Reflection and Transparency Notable Absences

28 June

Clinical Trial Data and the Risk of Bias

8 June

Getting Hack to Reality

28 May

C-TAP has not (yet) lived up to high expectations

19 April

A Pandemic Response Lacking Moral Leadership

23 March

MPs and MEPs Call for TRIPS Waiver

22 March

Challenging the IP Protection Framework

6 March

5 reasons to support the European Citizens’ Initiative No Profit On Pandemic

6 March

5 redenen om het Europees burgerinitiatief No Profit on Pandemic te steunen

10 February

Access to Medicines in Europe

18 January

The WHO Executive Board (EB148) in 2021

14 December

Access to medicines in the EU in 2020

11 December

There is no UHC without Universal Medicines Coverage

24 November

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

6 October

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

30 September

What do the next five years have in store for the European Medicines Agency?

20 August

Dutch institutions failing to register results of clinical trials

11 June

HAI Releases Annual Report 2019

7 May

Why TRIPS flexibilities are a crucial mechanism for access to medicines